Fundraising Fox
/Companies
Sign in

Rnav8 BIO

Laguna Niguel, US · Founded 2022 · Delaware corporation · 6 employees on LinkedIn · 5 known investors

Find your way into Rnav8 BIO

Sign up to see every warm intro you have to Rnav8 BIO

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Rnav8 BIO team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

RNAV8 Bio develops a toolkit for engineering mRNA therapeutics, optimizing non-coding sequences to improve expression and efficacy of mRNA-based treatments. The company serves pharmaceutical and biotech organizations seeking to expand the clinical application of mRNA technology.

AI & Machine LearningBiotech

Founders & leadership

Rnav8 BIO was founded in 2022 by Devan Shah and Michelle Lynn Hall.

DS
Devan ShahFounderDevan Shah brings expertise in nucleic acids, regenerative medicine, and computational biology, along with experience in business development, operations, and finance. He is co-founder and CEO of RNAV8 Bio, which develops optimization tools for mRNA therapeutics.
MLMichelle Lynn Hall
Michelle Lynn Hall

Investors · 5

Elmehøj Ventureslisted by Elmehøj VenturesCopenhagenvia Allan Rasmussen · inferred
Gaingelslisted by GaingelsNew York · $200K – $500K

How we know: gaingels.com · Not right? Tell us

Portal Innovationslisted by Portal InnovationsChicago
Service Provider Capitallisted by Service Provider CapitalVail

How we know: the VCSheet dataset · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$2M disclosed across 1 round · 2022

▶$2MraisedMar 2025 · 42 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Devan ShahExecutive Officer, Director
Offering amount
$3M
Amount sold
$2M
First sale
May 2022
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

RNAV8 Bio Joins Team Selected for ARPA-H Funding to Develop Programmable RNA Medicinesprweb.com · Sep 2026

Frequently asked questions

What does Rnav8 BIO do?
RNAV8 Bio develops a toolkit for engineering mRNA therapeutics, optimizing non-coding sequences to improve expression and efficacy of mRNA-based treatments. The company serves pharmaceutical and biotech organizations seeking to expand the clinical application of mRNA technology.
Who founded Rnav8 BIO?
Rnav8 BIO was founded by Devan Shah, Michelle Lynn Hall in 2022.
Who are Rnav8 BIO's investors?
Rnav8 BIO's investors include BioBrit, Elmehøj Ventures, Gaingels, Portal Innovations, Service Provider Capital.
How much funding has Rnav8 BIO raised?
Rnav8 BIO has disclosed $2M raised across 1 round.
Where is Rnav8 BIO headquartered?
Rnav8 BIO is headquartered in Laguna Niguel, US.